Clinical trial
The NeXT Study; The Netherlands XTC Toxicity Study
NCT00235768 · UMC Utrecht, Other · Completed
Key facts
| NCT number | NCT00235768 |
|---|---|
| Title | The NeXT Study; The Netherlands XTC Toxicity Study |
| Official title | Neurotoxicity of Ecstasy: Causality, Course and Clinical Relevance |
| Lead sponsor | UMC Utrecht, Other |
| Collaborators | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) University of Amsterdam, Bonger Institute of Criminology Erasmus Medical Center |
| Status | Completed |
| Study type | Observational |
| Conditions | Ecstasy (Drug), N-Methyl-3, 4-Methylenedioxymethamphetamine, Psychopathology |
| Enrollment | 225 |
| Start date | Apr 1, 2002 |
| Completion | Jul 1, 2005 |
| First posted | Oct 10, 2005 |
| Last update posted | Oct 10, 2005 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: